Evidence map›Paper›PMID 29278881›Full record

ArticleCancer biomarkers : section A of Disease markers2018

Effects of exogenous IL-37 on the biological characteristics of human lung adenocarcinoma A549 cells and the chemotaxis of regulatory T cells.

Yu-Hua Chen, Bi-Yun Zhou, Guo-Cai Wu, De-Quan Liao, Jing Li, Si-Si Liang, Xian-Jin Wu, Jun-Fa Xu, Yong-Hua Chen, Xiao-Qing Di and 1 more

RetractedAbstract readRetracted Publication
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

  • Retraction · 2022-01-14Investigation by Third Party · Manipulation of Images · Paper Mill · Unreliable Results and/or Conclusions · · see also: https://pubpeer.com/publications/8A7BA1711BF6D2ADC81850446D5CB8
  • Retracted
5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yu-Hua ChenDepartment of Clinical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Bi-Yun ZhouDepartment of Interventional Ward, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Guo-Cai WuDepartment of Hematology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
De-Quan LiaoDepartment of Clinical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Jing LiDepartment of Clinical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Si-Si LiangDepartment of Orthopedics, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Xian-Jin WuDepartment of Clinical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Jun-Fa XuDepartment of Clinical Immunology, Institute of Laboratory Medicine Guangdong Medical University, Dongguan 523808, Guangdong, China.
Yong-Hua ChenDepartment of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Xiao-Qing DiDepartment of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Qiong-Yan LinDepartment of Pathology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China.
Guangdong Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aims to investigate the effects of exogenous interleukin (IL)-37 on the biological characteristics of human lung adenocarcinoma A549 cells and the chemotaxis of regulatory T (Treg) cells.

methodsAfter isolating the CD4+ CD25+ Treg cells from the peripheral blood, flow cytometry was used to detect the purity of the Treg cells. A549 cells were divided into blank (no transfection), empty plasmid (transfection with pIRES2-EGFP empty plasmid) or IL-37 group (transfection with pIRES2-EGFP-IL-37 plasmid). RT-PCR was used to detect mRNA expression of IL-37 and ELISA to determine IL-37 and MMP-9 expressions. Western blotting was applied to detect the protein expressions of PCNA, Ki-67, Cyclin D1, CDK4, cleaved caspase-3 and cleaved caspase-9. MTT assay, flow cytometry, scratch test and transwell assay were performed to detect cell proliferation, cycle, apoptosis, migration and invasion. Effect of exogenous IL-37 on the chemotaxis of Treg cells was measured through transwell assay. Xenograft models in nude mice were eastablished to detect the impact of IL-37 on A549 cells.

resultsThe IL-37 group had a higher IL-37 expression, cell apoptosis in the early stage and percentage of cells in the G0/G1 phase than the blank and empty plasmid groups. The IL-37 group had a lower MMP-9 expression, optical density (OD), percentage of cells in the S and G2/M phases, migration, invasion and chemotaxis of CD4+CD25+ Foxp3+ Treg cells. The xenograft volume and weight of nude mice in the IL-37 group were lower than those in the blank and empty plasmid groups. Compared with the blank and empty plasmid groups, the IL-37 group had significantly reduced expression of PCNA, Ki-67, Cyclin D1 and CDK4 but elevated expression of cleaved caspase-3 and cleaved caspase-9.

conclusionTherefore, exogenous IL-37 inhibits the proliferation, migration and invasion of human lung adenocarcinoma A549 cells as well as the chemotaxis of Treg cells while promoting the apoptosis of A549 cells.

Indexed as

AdenocarcinomaAdenocarcinoma of LungAdolescentAdultAnimalsApoptosisBiomarkersCell CycleCell Line, TumorCell ProliferationChemotaxisDisease Models, AnimalFemaleHumansImmunophenotypingInterleukin-1BiomarkersIL37 protein, humanInterleukin-1biological characteristicchemotaxis and regulatory T cellsExogenous interleukin-37human lung adenocarcinoma A549 cells

Identifiers

PMID29278881
PMCPMC13078312
OpenAlexW2778590633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.